Portal de Periódicos da CAPES

Genetic Disease Before and After the Birth Event

1982; Wiley; Volume: 2; Issue: 1 Linguagem: Inglês

10.1111/j.1600-0897.1982.tb00083.x

2374-8184

Stephen D. Litwin,

Prenatal Screening and Diagnostics

American Journal of Reproductive ImmunologyVolume 2, Issue 1 p. 43-45 Genetic Disease Before and After the Birth Event STEPHEN D. LITWIN MD, Corresponding Author STEPHEN D. LITWIN MD Division of Human Genetics, Department of Medicine, The New York Hospital-Cornell Medical CenterDivision of Human Genetics, Department of Medicine, The New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, NY 10021.Search for more papers by this author STEPHEN D. LITWIN MD, Corresponding Author STEPHEN D. LITWIN MD Division of Human Genetics, Department of Medicine, The New York Hospital-Cornell Medical CenterDivision of Human Genetics, Department of Medicine, The New York Hospital-Cornell Medical Center, 525 East 68th Street, New York, NY 10021.Search for more papers by this author First published: February 1982 https://doi.org/10.1111/j.1600-0897.1982.tb00083.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Oster J, Mikkelsen M, Nielsen A. Mortality and life-table in Down's syndrome. Acta Paediatr Scand. 1975; 64: 322– 326. 2 Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. In: D Bergsma, DE Harrison, NW Paul, eds. Genetic Effects on Aging. National Foundation-March of Dimes, Birth Defects Original Articles Series. New York: Alan R. Liss, 1978; 14(1): 5– 40. 3 Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky R, Boss J. Thymic deficiency in Down's syndrome. Pediatrics. 1979; 63: 80– 87. 4 Franceschi C, Licastro F, Chircolo M, Bonetti F, Zanotti M, Fabris N, Mocchegiani E, Fantini MP, Paolucci P, Masi M. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J Immunol. 1981; 126: 2161– 2220. 5 Burgio GR, Nespoli L. Ageing, T Lymphocytes and Down's syndrome. Lancet. 1974; 2: 1580. 6 Seger R, Buchinger G, Stroder J. On the influence of age on immunity in Down's syndrome. Eur J Pediatr. 1977; 124: 77– 87. 7 Burgio GR, Ugasio AG, Nespoli L, Marcioni AF, Botelli AM, Pasquali F. Derangement of immunoglubulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol. 1975; 5: 600– 603. 8 Epstein LB, Epstein CJ. T-lymphocyte function and sensitivity to interferon in Trisomy 21. Cell Immunol. 1980; 51: 303– 318. 9 Cupples CG, Tan YH. Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome. Nature. 1977; 267: 165– 167. 10 Miller ME, Mellman WJ, Kohn G, Dietzi W Jr. Qualitative and quantitative deficiencies of immunoglobulin G (IgG) in newborns with Down's syndrome. Ann NY Acad Sci. 1970; 171: 512– 516. 11 Cederqvist LL, Spigelman S, Litwin SD. Decreased cord blood IgM and IgA in trisomy 21. Am J Reprod Immunol. 1981; 1: 62– 63. 12 Hawkes RA, Boughton CR, Schroeter DR. The antibody response of institutionalized Down's syndrome patients to seven microbial antigens. Clin Exp Immunol. 1978; 31: 298– 304. 13 Lopez V, Ochs HD, Thuline HC, Dabis SD, Wedgwood RJ. Defective antibody response to bacteriophage φx174 in Down's syndrome. J Pediatr. 1975; 86: 207– 211. 14 Fialkow PJ. Thyroid autoimmunity and Down's syndrome. Ann NY Acad Sci. 1970; 171: 500– 511. 15 Esber HJ, Barbarich M, Menninger FF Jr, Meshorer E, Monedjikova V, Rosenkrantz H. Hepatitis-associated antigen and immunoglobulin composition in patients with Down's anomaly. Am J Clin Pathol. 1973; 59: 872– 876. 16 Rosner F, Lee SL. Down's syndrome and acute leukemia: Myeloblastic or lymphoblastic? Report of 43 cases and review of the literature. Am J Med. 1972; 53: 203– 218. 17 Miller RW. Neoplasia and Down's syndrome. Ann NY Acad Sci. 1970; 171: 637– 644. 18 Pennman HG. Fatal infectious mononucleosis: A critical review. J Clin Pathol. 1970; 23: 765– 771. 19 Purtillo D, Paquin T, DeFlorio D, Virzi F, Sakhuja R. Immunodiagnosis and immunopathogenesis of the X-linked lymphoproliferative syndrome. Semin Hematol. 1979; 16: 309– 343. 20 Tosato G, Magrath J, Koski J, Dooley N, Blaese M. Activation of suppressor T cells during Epstein-Barr virus infection. New Engl J Med. 1979; 301: 1133– 1137. 21 Litwin SD, Zanjani ED. Lymphocytes suppressing both immunoglobulin production and erythroid differentiation in hypogammaglobulinemia. Nature. 1977; 266: 57– 58. 22 Eliasson R, Mossberg B, Camner P, Afzelius BA. The immotilecilia syndrome: A congenital ciliary abnormality as an etiologic factor in chronic airway infections and male sterility. N Engl J Med. 1977; 297: 1– 6. Volume2, Issue1February 1982Pages 43-45 ReferencesRelatedInformation